Apr 20, 2009
The VerteLoc™ system, which has been implanted in over 300 patients in the United States, will soon be launched in Europe.
Winston Salem, NC (PRWEB) April 20, 2009 — Winston-Salem, NC (PRWEB) April 20, 2009 — VG Innovations, Inc (VGI), announced today that it will soon launch its’ revolutionary new minimally invasive spine stabilization system, called VerteLoc™, in Europe.
VerteLoc™ is designed to address minor spinal instabilities by effectively stabilizing the spinal facets, which are multi-directional joints of the spinal column.
“The company has signed a lucrative distribution contract with a formidable European distributor,” stated VGI’s President and CEO, Dan Grayson. “The sales from Europe will serve to increase our overall 2009 revenue projections by 10 to 15%. We have plans to expand our distribution to cover a broader scope of the global market in 2010,” Grayson continued.
In the United States, the VerteLoc™ system has already made a significant difference in the way surgeons have chosen to address minor spinal instabilities in over 300 patients with more than 500 spinal levels implanted to date. The patent pending design of the VerteLoc™ implant, which combines two unique geometric shapes and innovative directional instrumentation, is designed to allow surgeons to replicate the VerteLoc™ procedure regarding a variety of spinal disease indications and surgical approaches.
Early clinical results, from a random selection of patients, has exhibited promising results. A clinical study to determine fusion rates as a stand-alone device and in combination with other applicable devices is planned to begin in Q4 2009.
The VerteLoc™ Minimally Invasive Spine Stabilization System is designed to allow earlier intervention in the continuum of spinal care. The procedure should prolong or prevent more invasive spine procedures in indicated patients, which would provide significant quality of life benefits versus traditional methods of spinal fusion.
Company Profile
VG Innovations, Inc, is a privately held company and was formed in late 2007. The company is in the business of developing and commercializing proprietary, implantable devices with a specific focus on minimally invasive surgical products that could provide better surgical solutions over present technology. The products are designed to treat specific spinal disease indications that affect millions of people. More information on the company and its products can be found at: www.verteloc.com